Data as of Aug 29
| +0.01 / +0.24%|
The 1 analysts offering 12-month price forecasts for Pain Therapeutics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +89.57% increase from the last price of 4.22.
The current consensus among 1 polled investment analysts is to Buy stock in Pain Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.